KVUE (Kenvue) Rega marang bathi mangsa ngarep
Kenvue Inc. (KVUE) possesses significant pricing power driven by brand loyalty and faces minimal geopolitical risks. The company's valuation based on forward P/E allows for the tracking of asset revaluation phases, with the metric currently fixed at 15.40. Business stability and a focus on health attract top-tier researchers and marketers to the team, guaranteeing them a reliable professional environment.
Ringkesan rincian data analitis Kenvue Health (KVUE)
- rega saiki lan proyeksi nilai saham:
- indikator valuasi pasar bisnis:
- data ekuitas miturut neraca:
- data tingkat utang lan likuiditas finansial:
Total Utang marang Modal Kenvue Inc.|KVUE - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Kenvue Inc.|KVUE - Kewajiban utang agregat|Rasio utang marang kapitalisasi buku Kenvue Inc|KVUE - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Kenvue|Likuiditas cepet kenvue.com
- rincian asil keuangan lan kelipatan valuasi:
KVUE - Bathi perusahaan|Bathi mangsa ngarep Kenvue Inc.|KVUE - Rasio rega marang bathi|Prakiraan rega marang bathi Kenvue Corp|KVUE - Pangali PEG|Pangali EV/EBITDA Kenvue Inc|KVUE - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Kenvue|KVUE - Bathi saben saham sajroning taun lumaku|Wutah bathi EPS kuartalan kenvue.com|KVUE - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Kenvue Inc.
- statistik dodolan lan pendapatan perusahaan:
Pambiji fundamental:KVUE Kenvue
The forward P/E ratio relates the current market value of a share to the expected earnings per share. This metric allows an investor to assess the capital payback period and the sustainability of the business model in real time. By analyzing the current forward P/E of the company, one can determine the degree of asset overvaluation. For Kenvue Inc. (KVUE), the stability of this indicator confirms the pricing power of its premium brands. However, any deviations would signal margin pressures or legal risks.
Analisis perusahaan pesaing
Prakiraan rega marang bathi HLN (Haleon)|VRNA (Verona Pharma PLC) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Jyong Biotech Corp MENS|Ligand Corp (LGND) - Rasio prakiraan rega marang bathi|AMRX: Prakiraan rega marang bathi|perrigo.com - Rasio kapitalisasi marang bathi mangsa ngarep|ALVO: Pangali Forward P/E|Liquidia Corp - Pangali mangsa ngarep rega marang bathi|GLPG (Galapagos Genomics) - Pangali Forward P/E|Rasio prakiraan rega marang bathi ANI Pharmaceuticals Corp ANIP|Rega marang bathi mangsa ngarep MannKind Corporation (MNKD)|AMPH (amphastar.com) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Pacira BioSciences, Inc. PCRX|Pangali Forward P/E ARS Pharmaceuticals Inc SPRY|Theravance - Pangali Forward P/E|Rasio prakiraan rega marang bathi Aquestive Corp|scpharmaceuticals.com (SCPH) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi mangsa ngarep TECX|Prakiraan rega marang bathi TNXP|Rega marang bathi mangsa ngarep SXTC|Prakiraan rega marang bathi EPRX (Eupraxia Pharmaceuticals)|Pangali Forward P/E BioHarvest Sciences Inc (BHST)|Pangali Forward P/E EXOZ (eXoZymes Inc)|Oramed (ORMP) - Rasio prakiraan rega marang bathi|ENTX: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi HYFT (MindWalk Holdings, Inc.)|ABVC: Pangali Forward P/E|CPIX - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep Quantum BioPharma Ltd|Rasio rega marang bathi mangsa ngarep FGEN (fibrogen.com)|Pangali Forward P/E TELO|Prakiraan rega marang bathi ranitherapeutics.com RANI|Synergy CHC - Prakiraan rega marang bathi|Kapitalisasi marang proyeksi bathi Rallybio Corp (RLYB)|LEXX - Rega marang bathi mangsa ngarep|PULM - Pangali Forward P/E|PTHL (ftzy.com.cn) - Prakiraan rega marang bathi|APM (Aptorum Group) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi LYRA|Pangali Forward P/E Impact BioMedical, Inc.|Pangali Forward P/E TNFA|YCBD - Rasio prakiraan rega marang bathi|Rega marang bathi mangsa ngarep PainReform PRFX|CYTO (Altamira Therapeutics Ltd) - Rasio rega marang bathi sing dikarepake|Lipella - Pangali Forward P/E|Pangali mangsa ngarep rega marang bathi OPTN (OptiNose Corp)|PIRS: Pangali Forward P/E|procapsgroup.com (PROC) - Pangali Forward P/E|Rega marang bathi mangsa ngarep Petros Pharmaceuticals, Inc.|QLI: Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep ACELYRIN, Inc. (SLRN)|Prakiraan rega marang bathi TFF Pharmaceuticals, Inc TFFP
